Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 4/20 | 0.86 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.73 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL2123749 | 1.00 | SLC22A1 (0.86) | SLC22A1SLC22A2TSHRALDH1A1TP53 | |
| Tetrabuthylammonium SCHEMBL4494449 | 0.97 | SLC22A1 (0.80) | SLC22A1SLC22A2TSHRALDH1A1TP53 | |
| Tetrabuthylammonium SCHEMBL1444822 | 0.97 | SLC22A1 (0.80) | SLC22A1SLC22A2TSHRALDH1A1TP53 | |
| Tetrabuthylammonium SCHEMBL226110 | 0.96 | SLC22A1 (0.92) | SLC22A1SLC22A2TSHRALDH1A1TP53 | |
| Tetrabuthylammonium SCHEMBL2580744 | 0.96 | SLC22A1 (0.92) | SLC22A1SLC22A2TSHRALDH1A1TP53 | |
| Tetrabuthylammonium SCHEMBL5144255 | 0.96 | SLC22A1 (0.92) | SLC22A1SLC22A2TSHRALDH1A1TP53 | |
| Tetrabuthylammonium SCHEMBL466 | 0.96 | SLC22A1 (0.92) | SLC22A1SLC22A2TSHRALDH1A1TP53 | |
| Tetrabuthylammonium SCHEMBL792649 | 0.96 | SLC22A1 (0.92) | SLC22A1SLC22A2TSHRALDH1A1TP53 | |
| Tetrabuthylammonium SCHEMBL8840674 | 0.96 | SLC22A1 (0.92) | SLC22A1SLC22A2TSHRALDH1A1TP53 | |
| Tetrabuthylammonium SCHEMBL633811 | 0.96 | SLC22A1 (0.92) | SLC22A1SLC22A2TSHRALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250387315-A1 | Dental Varnishes Based On Cationic Polymer Dispersions | IVOCLAR VIVADENT AG (LI) | 2025-12-25 | — | — | US | claimed |
| EP-3513777-B1 | METHOD FOR THE REMINERALISATION OF TEETH | IVOCLAR VIVADENT AG (LI) | 2023-10-04 | — | — | EP | claimed |
| US-11712405-B2 | Method for the remineralization of teeth | IVOCLAR VIVADENT AG (LI) | 2023-08-01 | — | — | US | claimed |
| CN-115010903-A | Silane terminated resin based on mercapto click reaction and synthetic method thereof | 郑州恩德富新材料科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| US-20220192939-A1 | Composition For The Remineralization Of Teeth | IVOCLAR VIVADENT AG (LI) | 2022-06-23 | — | — | US | claimed |
| EP-4014948-A1 | COMPOSITION FOR THE REMINERALISATION OF TEETH | Ivoclar Vivadent AG (LI) | 2022-06-22 | — | — | EP | claimed |
| CN-112055712-A | Processes and intermediates for preparing therapeutic compounds useful in the treatment of retroviral infections | 吉利德科学公司 | 2020-12-08 | — | — | CN | claimed |
| CN-109037774-B | Crosslinked polymer electrolyte suitable for lithium secondary battery and preparation method thereof | 哈尔滨工业大学无锡新材料研究院 | 2020-10-09 | — | — | CN | claimed |
| US-20190224082-A1 | METHOD FOR THE REMINERALIZATION OF TEETH | IVOCLAR VIVADENT AG (LI) | 2019-07-25 | — | — | US | claimed |
| US-7648742-B2 | Difluorosubstituted heterocyclic compounds and the use thereof in the form of components in liquid crystalline media | MERCK PATENT GMBH (DE) | 2010-01-19 | — | — | US | claimed |
| US-20090104144-A1 | Gypsum board with a fluorine-containing antifungal agent | QUICK-MED TECHNOLOGIES, INC. (US) | 2009-04-23 | — | — | US | claimed |
| US-20080071097-A1 | Difluorosubstituted Heterocyclic Compounds and the Use Thereof in the Form of Components in Liquid Crystalline Media | MERCK PATENT GMBH (DE) | 2008-03-20 | — | — | US | claimed |
| WO-2006012965-A1 | DIFLUOROSUBSTITUTED HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN THE FORM OF COMPONENTS IN LIQUID CRYSTALLINE MEDIA | MERCK PATENT GMBH (DE) | 2006-02-09 | — | — | WO | claimed |
| US-6773822-B2 | ANTIFUNGAL AGENT MAY BE PRESENT IN THE GYPSUM CORE AND/OR ON ONE OR BOTH OF THE PAPER FACINGS, AND MAY BE ENCAPSULATED IN A MATERIAL THAT RELEASES THE ANTIFUNGAL AGENT OVER TIME AND/OR UPON EXPOSURE TO MOISTURE. | TEMPLE-INLAND FOREST PRODUCTS CORPORATION | 2004-08-10 | — | — | US | claimed |
| EP-0189448-B1 | AGENT FOR THE FLUORIDATION OF ORGANIC COMPOUNDS PARTICULARLY ACETYLENIC COMPOUNDS, PREPARATION PROCESS THEREOF AND UTILIZATION THEREOF IN NUCLEOPHILIC SUBSTITUTION OR ADDITION REACTIONS | UNIVERSITE D'ANGERS (FR) | 1989-01-25 | — | — | EP | claimed |
| JP-11286465-A | — | — | None | — | — | JP | disclosed |
| JP-4264041-A | — | — | None | — | — | JP | disclosed |
| JP-H04264041-A | PRODUCTION OF DIFLUOROMETHYLENE COMPOUND | SAGAMI CHEM RES CENTER | 1992-09-18 | — | — | JP | disclosed |
| US-5011944-A | Substituted α-pyrones | CIBA-GEIGY CORPORATION (US) | 1991-04-30 | — | — | US | disclosed |
| EP-0344113-A2 | Substituted alpha-pyrones and naphthoquinones | CIBA-GEIGY AG (CH) | 1989-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080071097-A1 | Difluorosubstituted Heterocyclic Compounds and the Use Thereof in the Form of Components in Liquid Crystalline Media | C1S, CCND3, CCND2 | SLC22A1 2865/4885SLC22A2 2726/4885TSHR 2502/4885 |
| US-20250387315-A1 | Dental Varnishes Based On Cationic Polymer Dispersions | TUBA3C, DNMT1, TUBA1A | SLC22A1 1212/4885SLC22A2 1011/4885TSHR 1494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.